摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(adamantan-1-ylaminomethyl)cyclohexanol | 1443123-06-5

中文名称
——
中文别名
——
英文名称
4-(adamantan-1-ylaminomethyl)cyclohexanol
英文别名
Adamantan-1-yl-(1H-thieno[3,4-d]imidazol-2-ylmethyl)-amine;N-(1H-thieno[3,4-d]imidazol-2-ylmethyl)adamantan-1-amine
4-(adamantan-1-ylaminomethyl)cyclohexanol化学式
CAS
1443123-06-5
化学式
C16H21N3S
mdl
——
分子量
287.429
InChiKey
BQPIAQZMNFTRCD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    69
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    2-(氯甲基)-1H-噻吩并[3,4-d]咪唑金刚烷胺二氯甲烷methanol-dichloromethane 作用下, 以 二甲基亚砜 为溶剂, 反应 12.0h, 以to give the Adamantan-1-yl-(1H-thieno[3,4-d]imidazol-2-ylmethyl)-amine (5) (51.1 mg, 7% over two steps)的产率得到4-(adamantan-1-ylaminomethyl)cyclohexanol
    参考文献:
    名称:
    INHIBITORS TARGETING DRUG-RESISTANT INFLUENZA A
    摘要:
    提供了符合公式(Ia)或(Ib)的化合物,可以通过与M2跨膜蛋白和其他类似的病毒孔蛋白相互作用,调节流感病毒(例如流感A病毒)的活性。还提供了一种治疗流感A受影响的疾病状态或感染的方法,包括给予含有一个或多个符合公式(Ia′)或(Ib)的化合物的组合物。
    公开号:
    US20150191439A1
点击查看最新优质反应信息

文献信息

  • [EN] INHIBITORS TARGETING DRUG-RESISTANT INFLUENZA A<br/>[FR] INHIBITEURS CIBLANT LA GRIPPE A PHARMACORÉSISTANTE
    申请人:UNIV PENNSYLVANIA
    公开号:WO2013086131A1
    公开(公告)日:2013-06-13
    Provided are compounds according to formula (la) or (lb) as described herein, that are capable of modulating the activity of influenza viruses (e.g., influenza A virus), for example, via interaction with the M2 transmembrane protein, and other similar viroporins. Also provided are methods for treating an influenza A-affected disease state or infection comprising administering a composition comprising one or more compounds according to according to formulas (la') or (lb), as described herein.
    根据本文描述的公式(la)或(lb),提供了一些化合物,这些化合物能够调节流感病毒(例如流感A病毒)的活性,例如通过与M2跨膜蛋白以及其他类似的病毒孔蛋白相互作用。还提供了一种治疗流感A感染疾病状态或感染的方法,包括通过给予包含根据本文描述的公式(la')或(lb)的一个或多个化合物的组合物进行治疗。
  • US9884832B2
    申请人:——
    公开号:US9884832B2
    公开(公告)日:2018-02-06
查看更多

同类化合物

沙维拉唑 4H-吡咯并[1,2-a]噻吩并[3,2-D]咪唑 3H-噻吩并[2,3-d]咪唑-5-羧酸 3-甲基-1H-噻吩并[2,3-d]咪唑-2(3h)-酮 2-(氯甲基)-1H-噻吩并[3,4-d]咪唑 1H-噻吩并[3,2-D]咪唑-2(3H)-酮 1H-噻吩并[2,3-d]咪唑,1-乙烯基-(9CI) 1H-噻吩并(3,4-d)咪唑,2-(((5-甲基-2-吡啶基)甲基)亚硫酰基)- 1-甲基-1H-噻吩并[2,3-D]咪唑基-2(3H)-酮 1-乙烯基-1H-噻吩并[2,3-d]咪唑-5-羧酸 1,3-二氢噻吩并[3,4-d]咪唑-2-硫酮 2-(3-Chloro-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-(1-isopropyl-pyrrolo[3,2-b]pyridin-5-yl)-4-methyl-1,3-thiazole-5-carboxylic acid isopropyl ester 2-(3-cyano-1-isopropyl-pyrrolo[3,2-b]pyridin-5-yl)-4-methyl-1,3-thiazole-5-carboxylic acid isopropyl ester 2-(5-Methoxy-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-(4-ethoxy-benzyl)-1(3)H-thieno[2,3-d]imidazole 3,4,8-triamino-1H-pyrazolo<3,4-d>thieno<2,3-b>pyridin-7-carbonsaeure-ethylester 1-[2-(5-Methyl-pyridin-2-ylmethanesulfinyl)-3H-thieno[3,4-d]imidazol-6-yl]-ethanone 2-Oxo-2,3-dihydro-4-methyl-1H-thieno<3,4-d>imidazol 2-[4-(2,2,2-trifluoroethyloxy)-2-picolylsulfinyl]-4,6-dimethyl-1H-thieno[3,4-d]imidazole 1,2-dimethyl-N-{2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]ethyl}-1H-thieno[3, 4-d]imidazole-4-carboxamide 2-[4-(2,2,3,3,3-pentafluoropropyloxy)-2-picolylsulfinyl]-4,6-dimethyl-1H-thieno[3,4-d]imidazole 2-(3-Fluoro-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-[(3-methoxypyridin-2-yl)methylsulfanyl]-1H-thieno[3,4-d]imidazole 2-(5-Methyl-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrobromide 2-(3,5-Dimethyl-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride ethyl 6-ethyl-1-methyl-3-(1-methylethoxy)-5-[(thiophen-2-ylcarbonyl)amino]-1H-pyrrolo[2,3-b]pyridine-2-carboxylate 1H-thieno[3,4-d]imidazol-2(3H)-one 2-(4-piperidino-3-chloro-2-picolylmercapto)-1H-thieno[3,4-d]imidazole 4,6-Dimethyl-2-(pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride 2-(3-Methyl-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride ethyl 2-benzylthio-1-methoxymethyl-1H-thieno<2,3-d>imidazole-5-carboxylate 2-(6-Methyl-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride 2-(4-Methoxy-pyridin-2-ylmethylsulfanyl)-4,6-dimethyl-1H-thieno[3,4-d]imidazole; hydrochloride 2-(4-Ethoxy-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride 2-[(3-methylpyridin-2-yl)methylsulfanyl]-1H-thieno[3,4-d]imidazole Methyl 2-oxo-1,3-dihydrothieno[3,4-d]imidazole-4-carboxylate 2-oxo-2,3-dihydro-4-(δ-N-methylcarbamidobutyl)-1H-thieno<3,4-d>imidazole methyl 2-hexylthio-4-methylthieno[3,4-d]imidazole-6-carboxylate methyl 2-butylthio-4-methylthieno[3,4-d]imidazole-6-carboxylate dimethyl 4-methyl-4H-pyrrolo[3,2-d][1,3]thiazole-2,5-dicarboxylate 2-[4-(2,2,3,3,4,4,4-heptafluorobutyloxy)-2-picolylsulfinyl]-4,6-dimethyl-1H-thieno[3,4-d]imidazole 2-(3,5-Dimethyl-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 4,6-Dimethyl-2-(pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 2-(4-Ethoxy-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 2-(4-Methoxy-pyridin-2-ylmethanesulfinyl)-4,6-dimethyl-1H-thieno[3,4-d]imidazole 2-bromo-4H-pyrrolo[3,2-d]thiazole-5-carboxylic acid amide 4-phenyl-2-(pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-bromo-4H-pyrrolo[3,2-d]thiazole-5-carboxylic acid 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-4-(4-methoxyphenyl)-1H-thieno[3,4-d]imidazole